CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Relmada Therapeutics Inc Company Snapshot
Relmada Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Relmada Therapeutics Inc with three other companies in this sector in UNITED STATES : Protext Pharma Inc (2012 sales of $10,634.00 ), Ocular Therapeutix Inc ($10,000.00 of which 100% was Biopharmaceutical Preparations), and AV Therapeutics Inc ($7,980.00 of which 100% was Rice Mill).

Sales Analysis.
   
   
 
  Stock Performance Chart for Relmada Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (4/3/2020): 32.56
(Figures in U.S. Dollars)
1 Week -3.8%   13 Weeks -33.1%  
4 Weeks -15.4%   52 Weeks 390.4%  
 
Relmada Therapeutics Inc Key Data:
  Ticker: RLMD Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2012 Sales 7,941
(Year Ending Jan 2013).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 323,568,516
  Fiscal Yr Ends: June Shares Outstanding: 9,937,608
  Share Type: Common Closely Held Shares: 1,540,200
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.